← SynDRA
BTZ-043
SynDRA canonical compound SYN0027718 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Mechanism of action | DPRE1 inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- Bzt043
- BTZ-10526043
- (S)-2-(2-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl)-8-nitro-6-(trifluoromethyl)-4H-benzo[e][1,3]thiazin-4-one
- [2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-4-oxo-6-(trifluoromethyl)-1,3-benzothiazin-8-yl]azinic acid
- 2-((2S)-2-METHYL-1,4-DIOXA-8-AZASPIRO(4.5)DECAN-8-YL)-8-NITRO-6-TRIFLUOROMETHYL-4H-1,3-BENZOTHIAZIN-4-ONE
- 2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-4H-1,3-benzothiazin-4-one
- 2-[(3S)-3-methyl-1,4-dioxa-8-azaspiro[4.5]decan-8-yl]-8-nitro-6-(trifluoromethyl)-1,3-benzothiazin-4-one
- 4H-1,3-BENZOTHIAZIN-4-ONE, 2-((2S)-2-METHYL-1,4-DIOXA-8-AZASPIRO(4.5)DEC-8-YL)-8-NITRO-6-(TRIFLUOROMETHYL)-
- 4H-1,3-Benzothiazin-4-one, 2-[(2S)-2-methyl-1,4-dioxa-8-azaspiro[4.5]dec-8-yl]-8-nitro-6-(trifluoromethyl)-
- AC-35368
- AKOS030526000
- AS-74893
- BCP9000457
- BCPP000312
- BTZ043
- BTZ043-racemate
- CHEMBL1822872
- CS-5635
- DTXSID80151286
- EN300-23853592
- EX-A1012
- G55ZH52P57
- GTPL13034
- GTUIRORNXIOHQR-VIFPVBQESA-N
- HY-13579
- MFCD17215196
- MMV676603
- PBTZ 169
- Q27278777
- S1097_Selleck
- SCHEMBL2488829
- UNII-G55ZH52P57
- BTZ 043
- BTZ 10526043
- RefChem:1060493
- DTXCID7073777
- C17H16F3N3O5S
- orb1304035
Look up BTZ-043 in the interactive SynDRA portal →